Marico derives 72% of its domestic revenues from edible oil and 20% from hair oils. It has two well-known domestic brands Parachute and Saffola and has acquired a clutch of international personal care brands such as 'Camelia', 'Aromatic' and 'Magnoli... More
Pidilite is present in consumer products and speciality industrial products.Consumer products with a 79% sales share include art materials, adhesives, sealants, fabric care and car care products. Industrial products consist of adhesives, pigments, le... More
MARICO | PIDILITE INDUSTRIES | MARICO/ PIDILITE INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 47.8 | 102.3 | 46.7% | View Chart |
P/BV | x | 18.0 | 20.0 | 89.7% | View Chart |
Dividend Yield | % | 0.9 | 0.4 | 235.8% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
MARICO Mar-20 |
PIDILITE INDUSTRIES Mar-20 |
MARICO/ PIDILITE INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 404 | 1,710 | 23.6% | |
Low | Rs | 234 | 1,090 | 21.4% | |
Sales per share (Unadj.) | Rs | 56.7 | 143.6 | 39.5% | |
Earnings per share (Unadj.) | Rs | 8.1 | 22.1 | 36.6% | |
Cash flow per share (Unadj.) | Rs | 9.2 | 25.4 | 36.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 7.00 | 57.1% | |
Dividend yield (eoy) | % | 1.3 | 0.5 | 251.0% | |
Book value per share (Unadj.) | Rs | 23.5 | 87.7 | 26.8% | |
Shares outstanding (eoy) | m | 1,290.90 | 508.10 | 254.1% | |
Bonus/Rights/Conversions | - | ESOP | - | ||
Price / Sales ratio | x | 5.6 | 9.8 | 57.7% | |
Avg P/E ratio | x | 39.5 | 63.4 | 62.2% | |
P/CF ratio (eoy) | x | 34.8 | 55.1 | 63.2% | |
Price / Book Value ratio | x | 13.6 | 16.0 | 85.1% | |
Dividend payout | % | 49.5 | 31.7 | 156.2% | |
Avg Mkt Cap | Rs m | 411,474 | 711,315 | 57.8% | |
No. of employees | `000 | 1.7 | 6.1 | 27.8% | |
Total wages/salary | Rs m | 4,780 | 9,272 | 51.6% | |
Avg. sales/employee | Rs Th | 43,438.2 | 12,029.1 | 361.1% | |
Avg. wages/employee | Rs Th | 2,838.5 | 1,529.1 | 185.6% | |
Avg. net profit/employee | Rs Th | 6,193.6 | 1,850.3 | 334.7% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 73,150 | 72,945 | 100.3% | |
Other income | Rs m | 1,240 | 1,494 | 83.0% | |
Total revenues | Rs m | 74,390 | 74,439 | 99.9% | |
Gross profit | Rs m | 14,690 | 15,239 | 96.4% | |
Depreciation | Rs m | 1,400 | 1,699 | 82.4% | |
Interest | Rs m | 500 | 336 | 148.8% | |
Profit before tax | Rs m | 14,030 | 14,698 | 95.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -290 | 0 | - | |
Tax | Rs m | 3,310 | 3,477 | 95.2% | |
Profit after tax | Rs m | 10,430 | 11,221 | 93.0% | |
Gross profit margin | % | 20.1 | 20.9 | 96.1% | |
Effective tax rate | % | 23.6 | 23.7 | 99.7% | |
Net profit margin | % | 14.3 | 15.4 | 92.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 31,820 | 37,610 | 84.6% | |
Current liabilities | Rs m | 17,850 | 18,644 | 95.7% | |
Net working cap to sales | % | 19.1 | 26.0 | 73.5% | |
Current ratio | x | 1.8 | 2.0 | 88.4% | |
Inventory Days | Days | 69 | 47 | 148.1% | |
Debtors Days | Days | 27 | 54 | 49.4% | |
Net fixed assets | Rs m | 8,580 | 20,713 | 41.4% | |
Share capital | Rs m | 1,291 | 508 | 254.1% | |
"Free" reserves | Rs m | 29,000 | 44,048 | 65.8% | |
Net worth | Rs m | 30,291 | 44,556 | 68.0% | |
Long term debt | Rs m | 100 | 251 | 39.8% | |
Total assets | Rs m | 50,020 | 65,357 | 76.5% | |
Interest coverage | x | 29.1 | 44.7 | 64.9% | |
Debt to equity ratio | x | 0 | 0 | 58.5% | |
Sales to assets ratio | x | 1.5 | 1.1 | 131.0% | |
Return on assets | % | 21.9 | 17.7 | 123.6% | |
Return on equity | % | 34.4 | 25.2 | 136.7% | |
Return on capital | % | 46.9 | 33.6 | 139.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 3,830 | 6,010 | 63.7% | |
Fx outflow | Rs m | 1,534 | 9,110 | 16.8% | |
Net fx | Rs m | 2,295 | -3,100 | -74.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 12,180 | 12,796 | 95.2% | |
From Investments | Rs m | -440 | 1,029 | -42.7% | |
From Financial Activity | Rs m | -11,460 | -8,492 | 134.9% | |
Net Cashflow | Rs m | 450 | 5,335 | 8.4% |
Indian Promoters | % | 59.6 | 69.5 | 85.8% | |
Foreign collaborators | % | 0.1 | 0.6 | 16.7% | |
Indian inst/Mut Fund | % | 2.6 | 3.5 | 74.3% | |
FIIs | % | 31.0 | 15.7 | 197.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 6.7 | 10.7 | 62.6% | |
Shareholders | 37,128 | 44,398 | 83.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare MARICO With: AMAR REMEDIES ARCHIES K.S.OILS BAJAJ CONSUMER CARE KARUTURI GLOBAL
Compare MARICO With: P&G (US) UNILEVER PLC. (UK) HYPERMARCAS (Brazil)
Share markets in India are presently trading on a negative note. The BSE Sensex is trading up by 357 points, up 0.7% at 49,267 levels.
Here's an analysis of the annual report of MARICO for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of MARICO. Also includes updates on the valuation of MARICO.
Here's an analysis of the annual report of PIDILITE INDUSTRIES for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of PIDILITE INDUSTRIES. Also includes updates on the valuation of PIDILITE INDUSTRIES.
For the quarter ended September 2020, PIDILITE INDUSTRIES has posted a net profit of Rs 4 bn (up 9.8% YoY). Sales on the other hand came in at Rs 19 bn (up 4.1% YoY). Read on for a complete analysis of PIDILITE INDUSTRIES's quarterly results.
For the quarter ended September 2020, MARICO has posted a net profit of Rs 3 bn (up 8.3% YoY). Sales on the other hand came in at Rs 20 bn (up 8.7% YoY). Read on for a complete analysis of MARICO's quarterly results.
For the quarter ended June 2020, MARICO has posted a net profit of Rs 4 bn (up 23.8% YoY). Sales on the other hand came in at Rs 19 bn (down 11.1% YoY). Read on for a complete analysis of MARICO's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More